2. ARDS
ā¢ Acute respiratory distress syndrome (ARDS) is characterised
by non-cardiac pulmonary oedema and progressive
refractory hypoxaemia
ā¢ It is widely recognised as a severe form of acute respiratory
failure.
3. ETIOLOGY
Etiologies can be pulmonary or Non pulmonary.
These include:
ā¢ Pneumonia, sepsis, aspiration
ā¢ Shock (any cause)
ā¢ Trauma
ā¢ Metabolic, hematologic(eg DIC) and immunologic disorders.
ā¢ Inhaled agents, smoke, high concentration of oxygen, corrosive substances.
ā¢ Major surgery
ā¢ Fat or air embolism
5. Clinical Manifestations
ā¢ Dyspnoea, tachypnoea and anxiety are early manifestations
ā¢ Progressive respiratory distress develops, with increasing respiratory
rate, intercostal retractions and use of accessory muscles of
respiration
ā¢ Cyanosis develops that may not improve with oxygen administration.
ā¢ Breath sounds are initially clear, but crackles (rales) and rhonchi
develop later.
ā¢ As respiratory failure progresses, mental status changes such as
agitation, confusion and lethargy occur.
6. Diagnostic Evaluation
ā¢ The hallmark sign for ARDS is a shunt; hypoxemia remains despite
increasing oxygen therapy.
ā¢ ABG
ā¢ Chest X-ray exhibits bilateral infiltrates.
ā¢ Pulmonary artery catheter readings: pulmonary artery wedge
pressure >18 mm Hg.
ā¢ CT SCAN
ā¢ PFT
7. Management
ā¢ The underlying cause for ARDS must be determined so appropriate
treatment can be initiated.
ā¢ Ventilatory support with PEEP will be instituted. PEEP keeps the
alveoli open, thereby improving gas exchange. Therefore, a lower
oxygen concentration (Fio2) can be used to maintain satisfactory
oxygenation.
ā¢ Fluid management must be maintained. The patient may be
hypovolemic due to the movement of fluid into the interstitium of the
lung.
ā¢ inotropic medications
8. Management
ā¢ Corticosteroids are used infrequently due to the controversy
regarding benefits of usage.
ā¢ Treatment of any infections with appropriate antibiotics
ā¢ A SwanāGanz line may be placed to monitor pulmonary artery
pressures and cardiac output.
ā¢ Adequate nutrition should be initiated early and maintained
ā¢ Enteral or parenteral feeding is necessary to maintain nutritional
status and prevent tissue catabolism.
9. Managemntā¦
ā¢ Low-molecular-weight heparin may be ordered to prevent
thrombophlebitis and possible pulmonary embolus or disseminated
intravascular coagulation, a possible complication of ARDS
10. Complications
ā¢ Infections, such as pneumonia, sepsis.
ā¢ Respiratory complications, such as pulmonary emboli, barotrauma,
oxygen toxicity, subcutaneous emphysema, or pulmonary fibrosis.
ā¢ GI complications, such as stress ulcer, ileus.
ā¢ Cardiac complications, such as decreased cardiac output and
dysrhythmias.
ā¢ Renal failure, disseminated intravascular coagulation
12. Nursing Diagnoses
ā¢ Impaired gas exchange related to effects of near drowning evidenced
by increased respiration rate and decreasing oxygen saturations.
ā¢ Anxiety related to hypoxaemia evidenced by decreasing oxygen
saturations.
ā¢ Risk of decreased cardiac output related to mechanical ventilation
evidenced by decreasing blood pressure and increasing heart rate.
ā¢ Risk of injury related to endotracheal intubation evidenced by
haemoptysis.
13. Planning
ā ā Obtain all necessary supplies and radiology in preparation for
intubation and mechanical ventilation.
ā ā Explain the purpose and procedure of intubation.
ā ā Provide an opportunity to express fears related to intubation and
mechanical ventilation; answer questions and provide reassurance.
ā ā Discuss communication strategies while intubated; obtain a magic
slate.
14. Expected outcomes
ā¢ Breathe effectively with the mechanical ventilator.
ā¢ Demonstrate improved oxygen saturation, ETCO2 and ABG values
ā¢ Express fears related to intubation and mechanical ventilation.
ā¢ Demonstrate reduced anxiety levels (relaxed facial expression, ability
to rest).
ā¢ Maintain adequate cardiac output and tissue perfusion.
ā¢ Tolerate endotracheal intubation and mechanical ventilation without
evidence of infection or barotrauma.
15. Nursing Interventions
ā¢ Monitor oxygen saturation and ETCO2 levels every 30 to 60 minutes
initially after mechanical ventilation is commenced; report changes to
the doctor.
ā¢ Obtain ABGs as ordered or indicated; monitor and report results.
ā¢ Suction via endotracheal tube as needed to maintain clear airways.
ā¢ Provide periods of uninterrupted rest.
ā¢ Monitor vital signs every 1 to 2 hours.
ā¢ Assess skin colour, capillary refill and the presence of oedema every 4
hours.
16. Nursing managementā¦
ā¢ Monitor urine output hourly; report output of less than 30 mL per
hour.
ā¢ Assess lung sounds and chest excursion every 1 to 2 hours